Use of Biomarkers in Clinical Trials of Alzheimer Disease: From Concept to Application

Author： Wu Liyong   Rosa-Neto Pedro   Gauthier Serge  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.15, Iss.6, 2011-12, pp. : 313-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eligibility of Alzheimer's Disease Clinic Patients for Clinical Trials

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 45, Iss. 8, 1997-08 ,pp. : 923-928

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials

By Winblad Bengt   Black Sandra E.   Homma Akira   Schwam Elias M.   Moline Margaret   Xu Yikang   Perdomo Carlos A.   Swartz Jina   Albert Kenneth  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2577-2587

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood

By Lönneborg Anders  

Molecular Diagnosis & Therapy, Vol. 12, Iss. 5, 2008-01 ,pp. : 307-320

Adis International

Access to resources Recommend Favorite

The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease

By Engelborghs Sebastiaan   >  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 3, 2012-06 ,pp. : 135-141

Adis International

Access to resources Recommend Favorite

Small molecule biomarkers in Alzheimer’s disease

By Kim Min   Legido-Quigley Cristina  

OCL (Oilseeds, Crops, fats & Lipids), Vol. 25, Iss. 4, 2018-08 ,pp. : D404-D404

Edp Sciences

Access to resources Recommend Favorite